search
Back to results

WEANING-Study: "Weaning by Early Versus lAte Tracheostomy iN supratentorIal iNtracerebral Bleedings (WEANING)

Primary Purpose

Intracerebral Hemorrhage

Status
Terminated
Phase
Phase 2
Locations
Germany
Study Type
Interventional
Intervention
Early tracheostomy
Late tracheostomy
Sponsored by
University of Erlangen-Nürnberg Medical School
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Intracerebral Hemorrhage focused on measuring supratentorial intracerebral hemorrhage, tracheostomy, sedation, weaning

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients requiring intubation / mechanical ventilation
  • Supratentorial intracerebral hemorrhage (including:)
  • primary spontaneous ICH (lobar / deep)
  • ICH related to anticoagulant therapy
  • with or without intraventricular hemorrhage
  • with or without occlusive and / or communicating hydrocephalus
  • Hematoma volume >0 ml and <60 ml
  • Age 18 - 85 years
  • Informed consent (legal representative)

Exclusion Criteria:

  • Patients with elective intubation/ventilation for EVD placement
  • Patients with "do not treat" / "do not resuscitate" orders, severe co- morbidity and life expectancy of less than 3 months
  • Absent consent of relatives for invasive (neuro-)critical care
  • Contraindication for tracheostomy
  • Other than primary supratentorial ICH or supratentorial ICH related to oral anticoagulants
  • Pre-existing COPD (known/treated)
  • Pre-existing congestive heart failure (≥3 NYHA)
  • Pre-existing modified Rankin Scale (≥4)

Sites / Locations

  • University or Erlangen-Nuremberg

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

early tracheostomy

late tracheostomy

Arm Description

see study description

Compared to the "early tracheostomy"-group, those patients who have been randomized to "late tracheostomy" will undergo conventional tracheostomy between day 12 - 14 if extubation fails

Outcomes

Primary Outcome Measures

Cumulative time requiring mechanical ventilation and Overall duration of neurocritical care
Primary End-points: Cumulative time requiring mechanical ventilation Overall duration of neurocritical care

Secondary Outcome Measures

Incidence of respirator-associated pneumonia
Cumulative consumption of sedative drugs
Incidence of episodes with increased intracranial pressure
In-hospital mortality
3-months functional outcome (mRS)
functional outcome after 3 months using the modified Rankin Scale

Full Information

First Posted
July 26, 2010
Last Updated
April 25, 2014
Sponsor
University of Erlangen-Nürnberg Medical School
search

1. Study Identification

Unique Protocol Identification Number
NCT01176214
Brief Title
WEANING-Study: "Weaning by Early Versus lAte Tracheostomy iN supratentorIal iNtracerebral Bleedings
Acronym
WEANING
Official Title
Weaning by Early Versus lAte Tracheostomy iN supratentorIal iNtracerebral Bleedings
Study Type
Interventional

2. Study Status

Record Verification Date
April 2014
Overall Recruitment Status
Terminated
Why Stopped
slow recruitment of patients
Study Start Date
July 2010 (undefined)
Primary Completion Date
April 2014 (Actual)
Study Completion Date
April 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Erlangen-Nürnberg Medical School

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: One third of all ICH patients require intubation and mechanical ventilation and 1/3 of all ventilated patients require tracheostomy (i.e.≈10% of all ICH patients require tracheostomy). As shown previously, predisposing factors for tracheostomy are hematoma volume, hemorrhage location, presence of intraventricular hemorrhage (IVH), and occlusive hydrocephalus as well as presence of COPD (Huttner HB et al 2006 CVD). Sustained restricted vigilance and impaired consciousness after ICH is likely to result in failure of extubation, raise in incidence of ventilator-associated pneumonia, increased amount of sedative drugs and prolonged duration of neurocritical care. Hence an early tracheostomy may be beneficial in terms of reduced duration of mechanical ventilation. Basic hypothesis: Compared to patients with conventional ("late") tracheostomy between day 12 - 14, patients with "early" tracheostomy within 72h after admission will have: shorter cumulative time of mechanical ventilation less incidence of ventilator-associated pneumonia less consumption of sedative drugs shorter duration of stay in neurocritical care unit Randomization: Consecutive eligible patients are randomly assigned to Either "early" tracheostomy within 72h after hospital admission Or "late" tracheostomy (= control group; undergoing conventional tracheostomy between day 12 - 14 if extubation fails) Both groups receive plastic tracheostomy

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intracerebral Hemorrhage
Keywords
supratentorial intracerebral hemorrhage, tracheostomy, sedation, weaning

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
7 (Actual)

8. Arms, Groups, and Interventions

Arm Title
early tracheostomy
Arm Type
Experimental
Arm Description
see study description
Arm Title
late tracheostomy
Arm Type
Active Comparator
Arm Description
Compared to the "early tracheostomy"-group, those patients who have been randomized to "late tracheostomy" will undergo conventional tracheostomy between day 12 - 14 if extubation fails
Intervention Type
Procedure
Intervention Name(s)
Early tracheostomy
Intervention Description
Patients with supratentorial ICH who require mechanical ventilation, fulfill the inclusion criteria, and have been randomized to the "treatment arm" will receive an early tracheostomy within 72h after symptom onset.
Intervention Type
Procedure
Intervention Name(s)
Late tracheostomy
Intervention Description
Compared to the "early tracheostomy"-group, those patients who have been randomized to "late tracheostomy" will undergo conventional tracheostomy between day 12 - 14 if extubation fails
Primary Outcome Measure Information:
Title
Cumulative time requiring mechanical ventilation and Overall duration of neurocritical care
Description
Primary End-points: Cumulative time requiring mechanical ventilation Overall duration of neurocritical care
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Incidence of respirator-associated pneumonia
Time Frame
30 days
Title
Cumulative consumption of sedative drugs
Time Frame
30 days
Title
Incidence of episodes with increased intracranial pressure
Time Frame
30 days
Title
In-hospital mortality
Time Frame
30 days
Title
3-months functional outcome (mRS)
Description
functional outcome after 3 months using the modified Rankin Scale
Time Frame
90 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients requiring intubation / mechanical ventilation Supratentorial intracerebral hemorrhage (including:) primary spontaneous ICH (lobar / deep) ICH related to anticoagulant therapy with or without intraventricular hemorrhage with or without occlusive and / or communicating hydrocephalus Hematoma volume >0 ml and <60 ml Age 18 - 85 years Informed consent (legal representative) Exclusion Criteria: Patients with elective intubation/ventilation for EVD placement Patients with "do not treat" / "do not resuscitate" orders, severe co- morbidity and life expectancy of less than 3 months Absent consent of relatives for invasive (neuro-)critical care Contraindication for tracheostomy Other than primary supratentorial ICH or supratentorial ICH related to oral anticoagulants Pre-existing COPD (known/treated) Pre-existing congestive heart failure (≥3 NYHA) Pre-existing modified Rankin Scale (≥4)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hagen B Huttner, MD
Organizational Affiliation
Department of Neurology, University of Erlangen-Nuremberg, Germany
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Martin Köhrmann, MD
Organizational Affiliation
Department of Neurology, University of Erlangen, Germany
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Dimitre Staykov, MD
Organizational Affiliation
Department of Neurology, University of Erlangen, Germany
Official's Role
Study Director
Facility Information:
Facility Name
University or Erlangen-Nuremberg
City
Erlangen
ZIP/Postal Code
91054
Country
Germany

12. IPD Sharing Statement

Learn more about this trial

WEANING-Study: "Weaning by Early Versus lAte Tracheostomy iN supratentorIal iNtracerebral Bleedings

We'll reach out to this number within 24 hrs